its not a loss.
The consolidated entity recorded a profit after income tax for the 6 month period to 31 December 2020 of $11.0 million (December 2019: loss $5.23 million). The result was impacted by a number of key factors including:● Revenue from continuing operations amounted to $68.09 million, compared to $32.98 million in the previouscorresponding period, with increased sales of copper, zinc and lead concentrates and more favourable metal pricesas compared to the previous corresponding period;● Net realised and unrealised foreign exchange losses increased by $1.05 million as compared to the previouscorresponding period with foreign exchange losses of $1.19 million in the current period as compared to foreignexchange losses of $0.14 million realised in the prior corresponding period;● Sales realisation costs increased from $10.28 million at December 2019 to $12.68 million at December 2020 with theincreased cost of realising higher sales tonnage (up 62%) being substantially offset by decreased treatment chargesper tonne of zinc concentrate (period on period decrease of AUD 270 / tonne); and● Production costs (excluding movement in ore and concentrate stocks on hand) increased from $17.47 million atDecember 2019 to $21.49 million at December 2020 (refer note 4 of accounts), primarily due to higher tonnes being mined and processed at the Thalanga Operation.
- Forums
- ASX - By Stock
- Ann: Half Year Report - 31 December 2020
its not a loss. The consolidated entity recorded a profit after...
Featured News
Add RVR (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online